Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Reply to Tosh et al.: Quantitative analyses of cultural evolution require engagement with historical and archaeological research.

Currie TE, Turchin P, Whitehouse H, François P, Feeney K, Mullins D, Hoyer D, Collins C, Grohmann S, Savage P, Mendel-Gleason G, Turner E, Dupeyron A, Cioni E, Reddish J, Levine J, Jordan G, Brandl E, Williams A, Cesaretti R, Krueger M, Ceccarelli A, Figliulo-Rosswurm J, Tuan PJ, Peregrine P, Marciniak A, Preiser-Kapeller J, Kradin N, Korotayev A, Palmisano A, Baker D, Bidmead J, Bol P, Christian D, Cook C, Covey A, Feinman G, Júlíusson ÁD, Kristinsson A, Miksic J, Mostern R, Petrie C, Rudiak-Gould P, Ter Haar B, Wallace V, Mair V, Xie L, Baines J, Bridges E, Manning J, Lockhart B, Bogaard A, Spencer C.

Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E5841-E5842. doi: 10.1073/pnas.1807312115. Epub 2018 Jun 14. No abstract available.

PMID:
29903903
2.

Quantitative historical analysis uncovers a single dimension of complexity that structures global variation in human social organization.

Turchin P, Currie TE, Whitehouse H, François P, Feeney K, Mullins D, Hoyer D, Collins C, Grohmann S, Savage P, Mendel-Gleason G, Turner E, Dupeyron A, Cioni E, Reddish J, Levine J, Jordan G, Brandl E, Williams A, Cesaretti R, Krueger M, Ceccarelli A, Figliulo-Rosswurm J, Tuan PJ, Peregrine P, Marciniak A, Preiser-Kapeller J, Kradin N, Korotayev A, Palmisano A, Baker D, Bidmead J, Bol P, Christian D, Cook C, Covey A, Feinman G, Júlíusson ÁD, Kristinsson A, Miksic J, Mostern R, Petrie C, Rudiak-Gould P, Ter Haar B, Wallace V, Mair V, Xie L, Baines J, Bridges E, Manning J, Lockhart B, Bogaard A, Spencer C.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E144-E151. doi: 10.1073/pnas.1708800115. Epub 2017 Dec 21.

3.

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.

Ostergren J, Poulter NR, Sever PS, Dahlöf B, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E; ASCOT investigators.

J Hypertens. 2008 Nov;26(11):2103-11. doi: 10.1097/HJH.0b013e328310e0d9.

PMID:
18854748
4.

Effect of ximelagatran and warfarin on stroke subtypes in atrial fibrillation.

Teitelbaum JS, von Kummer R, Gjesdal K, Kristinsson A, Gahn G, Albers GW; SPORTIF Executive Steering Committee.

Can J Neurol Sci. 2008 May;35(2):160-5.

PMID:
18574928
5.

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.

Sever PS, Poulter NR, Dahlof B, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes G, Mehlsen J, Nieminen MS, O'Brien ET, Ostergren J; ASCOT Investigators.

Eur Heart J. 2008 Feb;29(4):499-508. doi: 10.1093/eurheartj/ehm583. Epub 2008 Jan 5.

PMID:
18175773
6.

Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.

Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, Mehlsen J, Nieminem M, O'Brien E, Ostergren J; ASCOT Steering Committee Members.

Eur Heart J. 2006 Dec;27(24):2982-8. Epub 2006 Dec 4. Erratum in: Eur Heart J. 2007 Jan;28(1):142.

PMID:
17145722
7.

Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials.

Frazier CG, Shah SH, Armstrong PW, Bhapkar MV, McGuire DK, Sadowski Z, Kristinsson A, Aylward PE, Klein WW, Weaver WD, Newby LK; SYMPHONY and the Second SYMPHONY Investigators.

Am Heart J. 2005 Dec;150(6):1260-7.

PMID:
16338269
8.

Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes.

Eisenstein EL, McGuire DK, Bhapkar MV, Kristinsson A, Hochman JS, Kong DF, Califf RM, Van de Werf F, Yancy WS Jr, Newby LK.

Am J Med. 2005 Sep;118(9):981-90.

PMID:
16164884
9.

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

Poulter NR, Wedel H, Dahlöf B, Sever PS, Beevers DG, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, Pocock S; ASCOT Investigators.

Lancet. 2005 Sep 10-16;366(9489):907-13.

PMID:
16154017
10.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators.

Lancet. 2005 Sep 10-16;366(9489):895-906.

PMID:
16154016
11.

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.

Hakonarson H, Thorvaldsson S, Helgadottir A, Gudbjartsson D, Zink F, Andresdottir M, Manolescu A, Arnar DO, Andersen K, Sigurdsson A, Thorgeirsson G, Jonsson A, Agnarsson U, Bjornsdottir H, Gottskalksson G, Einarsson A, Gudmundsdottir H, Adalsteinsdottir AE, Gudmundsson K, Kristjansson K, Hardarson T, Kristinsson A, Topol EJ, Gulcher J, Kong A, Gurney M, Thorgeirsson G, Stefansson K.

JAMA. 2005 May 11;293(18):2245-56.

PMID:
15886380
12.

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Sever PS, Poulter NR, Dahlöf B, Wedel H, Collins R, Beevers G, Caulfield M, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J.

Diabetes Care. 2005 May;28(5):1151-7.

PMID:
15855581
13.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators.

Drugs. 2004;64 Suppl 2:43-60.

PMID:
15765890
14.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators.

Lancet. 2003 Apr 5;361(9364):1149-58.

PMID:
12686036
15.

Early statin initiation and outcomes in patients with acute coronary syndromes.

Newby LK, Kristinsson A, Bhapkar MV, Aylward PE, Dimas AP, Klein WW, McGuire DK, Moliterno DJ, Verheugt FW, Weaver WD, Califf RM; SYMPHONY and 2nd SYMPHONY Investigators. Sibrafiban vs Aspirin to Yield Maximun Protection From Ischemic Heart Events Post-acute Coronary Syndromes.

JAMA. 2002 Jun 19;287(23):3087-95.

PMID:
12069671
16.

Linkage of essential hypertension to chromosome 18q.

Kristjansson K, Manolescu A, Kristinsson A, Hardarson T, Knudsen H, Ingason S, Thorleifsson G, Frigge ML, Kong A, Gulcher JR, Stefansson K.

Hypertension. 2002 Jun;39(6):1044-9.

17.

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.

Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE.

N Engl J Med. 1998 Apr 30;338(18):1248-57.

18.

[A prospective study of oral anticoagulation therapy monitored with the P&P-test.].

Haraldsson M, Onundarson PT, Gudmundsdottir BR, Einarsdottir KA, Kristinsson A, Palsson K, Petursson MK.

Laeknabladid. 1998 Jan;84(1):32-40. Icelandic.

PMID:
19667428
19.

Performance of prothrombin-proconvertin time as a monitoring test of oral anticoagulation therapy.

Haraldsson HM, Onundarson PT, Einarsdóttir KA, Guõmundsdóttir BR, Pétursson MK, Pálsson K, Kristinsson A.

Am J Clin Pathol. 1997 Jun;107(6):672-80.

PMID:
9169664
20.

[A left main coronary artery arising from the pulmonary artery. Case report.].

Gudbjartsson T, Torfason B, Kristinsson A, Helgason H, Magnusson J.

Laeknabladid. 1997 Feb;83(2):103-7. Icelandic.

PMID:
19679916

Supplemental Content

Loading ...
Support Center